Literature DB >> 7814988

Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma.

M Jeziorska1, N Y Haboubi, P F Schofield, Y Ogata, H Nagase, D E Woolley.   

Abstract

Gelatinase B (92 kD, matrix metalloproteinase-9, MMP-9), an enzyme capable of degrading several connective tissue components, was demonstrated by immunolocalization in all specimens of colorectal carcinoma (n = 40), but its distribution between specimens was variable. MMP-9 expression was more frequently observed in advanced tumour stages and was especially prevalent at the side and deep margins of the tumours, and ulceration sites. MMP-9 staining was observed for transformed epithelial cells, macrophages and neutrophils, but seldom for vascular or stromal cells. By contrast, the enzyme was absent from epithelial cells of normal mucosal tissue. Immunostaining of type IV collagen, the major structural component of basement membranes, revealed a general depletion or loss of these structures both within the tumours and at the tumour margins. Dual immunolocalization of MMP-9 and type IV collagen demonstrated that MMP-9 expression at specific sites in the tumour was often inversely related to the distribution of type IV collagen. MMP-9 expression was most pronounced at the invasive tumour margins and in microfoci where tumour cells were in close proximity to inflammatory cells. Such observations support the concept that localized proteolytic and collagenolytic activities contribute to the invasive properties of colorectal tumours.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814988     DOI: 10.1007/bf00290191

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  33 in total

1.  Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression.

Authors:  A D'Errico; S Garbisa; L A Liotta; V Castronovo; W G Stetler-Stevenson; W F Grigioni
Journal:  Mod Pathol       Date:  1991-03       Impact factor: 7.842

Review 2.  Basement membranes in human cancer.

Authors:  R Albrechtsen; U M Wewer; L A Liotta
Journal:  Pathol Annu       Date:  1986

Review 3.  Matrix metalloproteinases: a review.

Authors:  H Birkedal-Hansen; W G Moore; M K Bodden; L J Windsor; B Birkedal-Hansen; A DeCarlo; J A Engler
Journal:  Crit Rev Oral Biol Med       Date:  1993

4.  Loss of basement membrane components by invasive tumors but not by their benign counterparts.

Authors:  S H Barsky; G P Siegal; F Jannotta; L A Liotta
Journal:  Lab Invest       Date:  1983-08       Impact factor: 5.662

5.  Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells.

Authors:  E J Bernhard; R J Muschel; E N Hughes
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

6.  Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity.

Authors:  J Juarez; G Clayman; M Nakajima; K K Tanabe; H Saya; G L Nicolson; D Boyd
Journal:  Int J Cancer       Date:  1993-08-19       Impact factor: 7.396

7.  Tumour basement membrane laminin in adenocarcinoma of rectum: an immunohistochemical study of biological and clinical significance.

Authors:  S J Forster; I C Talbot; D G Clayton; D R Critchley
Journal:  Int J Cancer       Date:  1986-06-15       Impact factor: 7.396

8.  Prognostic value of tumor "budding" in patients with colorectal cancer.

Authors:  K Hase; C Shatney; D Johnson; M Trollope; M Vierra
Journal:  Dis Colon Rectum       Date:  1993-07       Impact factor: 4.585

9.  Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1 beta and a protein kinase C activator.

Authors:  Y Ogata; M A Pratta; H Nagase; E C Arner
Journal:  Exp Cell Res       Date:  1992-08       Impact factor: 3.905

10.  Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion.

Authors:  H Watanabe; I Nakanishi; K Yamashita; T Hayakawa; Y Okada
Journal:  J Cell Sci       Date:  1993-04       Impact factor: 5.285

View more
  10 in total

1.  Histopathological and radiological reporting in rectal cancer: concepts and controversies, facts and fantasies.

Authors:  S Balyasnikova; N Haboubi; B Moran; G Brown
Journal:  Tech Coloproctol       Date:  2016-12-07       Impact factor: 3.781

2.  Antitumor activity of anti-type IV collagenase monoclonal antibody and its lidamycin conjugate against colon carcinoma.

Authors:  Liang Li; Yun-Hong Huang; Yi Li; Feng-Qiang Wang; Bo-Yang Shang; Yong-Su Zhen
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

3.  Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.

Authors:  Vesna V Dragutinović; Nevena V Radonjić; Nataša D Petronijević; Svetislav B Tatić; Ivan B Dimitrijević; Nebojša S Radovanović; Zoran V Krivokapić
Journal:  Mol Cell Biochem       Date:  2011-05-04       Impact factor: 3.396

4.  More advanced or aggressive colorectal cancer is associated with a higher incidence of "high-grade intraepithelial neoplasia" on biopsy-based pathological examination.

Authors:  X B Wei; X H Gao; H Wang; C G Fu; W Q Zheng; J M Zheng; W Zhang; L J Liu
Journal:  Tech Coloproctol       Date:  2012-04-12       Impact factor: 3.781

5.  Advanced colorectal carcinomas measuring 20 mm or less exhibit markedly higher invasiveness despite their size.

Authors:  Yasuhiro Kunii; Toshiki Kamano; Yuichi Tomiki; Shu Hirai; Shinji Kasamaki; Kazuhiro Sakamoto
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

6.  JNK suppression is essential for 17β-Estradiol inhibits prostaglandin E2-Induced uPA and MMP-9 expressions and cell migration in human LoVo colon cancer cells.

Authors:  Hsi-Hsien Hsu; Wei-Syun Hu; Yueh-Min Lin; Wei-Wen Kuo; Li-Mien Chen; Wei-Kung Chen; Jin-Ming Hwang; Fuu-Jen Tsai; Chung-Jung Liu; Chih-Yang Huang
Journal:  J Biomed Sci       Date:  2011-08-22       Impact factor: 8.410

7.  Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model.

Authors:  S A Watson; T M Morris; S L Parsons; R J Steele; P D Brown
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

8.  Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer.

Authors:  E W Steyerberg; H J Keizer; S D Fosså; D T Sleijfer; D F Bajorin; J P Donohue; J D Habbema
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

9.  Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells.

Authors:  Z S Zeng; J G Guillem
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

10.  Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer.

Authors:  A Kumar; H M Collins; J H Scholefield; S A Watson
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.